Gouvernance Daiichi Sankyo Company, Limited

4568

JP3475350009

Produits pharmaceutiques

Marché Fermé - Japan Exchange Autres places de cotation 08:30:00 10/07/2026			Varia. 5j.	Varia. 1 janv.
2 730,50 ^JPY	-0,09%		+3,06%	-18,44%

08/07	Les bourses européennes clôturent en forte baisse mercredi ; les prix du pétrole s'envolent avec la reprise du conflit entre les États-Unis et l'Iran	MT
08/07	AstraZeneca et Daiichi proches d'un accord sur le prix de l'Enhertu au Royaume-Uni - Bloomberg	AN

Comité Exécutif: Daiichi Sankyo Company, Limited

Dirigeant

Fonctions occupéesDepuis

Hiroyuki Okuzawa

62 ans

Chief Executive Officer	01/04/2025
President	01/04/2024

Shangdai Cai

Compliance Officer

Miyuki Arai

Comptroller/Controller/Auditor

01/04/2023

Tomohiro Kodama

Director of Finance/CFO	01/04/2026
Investor Relations Contact	01/04/2022

Ueno Shizuko

61 ans

Chief Tech/Sci/R&D Officer

01/04/2020

Terumichi Yokoyama

60 ans

Comptroller/Controller/Auditor

01/04/2021

Matt Allegrucci

Compliance Officer

01/04/2024

Naoto Tsukaguchi

General Counsel

Takashi Matsumoto

62 ans

Human Resources Officer

01/04/2019

John Tsai

59 ans

Chief Tech/Sci/R&D Officer

01/04/2026

Composition du Conseil d'Administration: Daiichi Sankyo Company, Limited

Administrateur

ComitésDepuis

Akihiro Watanabe

67 ans

Nominating Committee Chair	23/06/2025
Nominating Committee	01/03/2026

Yo Honma

70 ans

Compensation Committee Chair

17/06/2024

Yasuhiro Komatsu

68 ans

Director/Board Member	01/06/2022
Independent Dir/Board Member	01/06/2022

Takashi Matsumoto

62 ans

Director/Board Member

17/06/2024

Takaaki Nishii

66 ans

Director/Board Member	01/06/2023
Independent Dir/Board Member	01/06/2023

Ueno Shizuko

61 ans

Director/Board Member

23/06/2025

Kenneth Keller

63 ans

Director/Board Member

01/06/2025

Reiko Kinoshita

62 ans

Director/Board Member	23/06/2025
Independent Dir/Board Member	23/06/2025

Hiroyuki Okuzawa

62 ans

Director/Board Member

21/06/2021

Dernières Nominations: Daiichi Sankyo Company, Limited

18/05	Bourse : Publicis casse sa tirelire, fusion géante aux USA et grève interdite chez Samsung
16/04	Aktis Oncology, Inc. annonce des remaniements au sein de son conseil d'administration	CI
16/04	Daiichi Sankyo Company, Limited annonce la nomination de Takashi Matsumoto au poste de Chief Corporate Affairs Officer et responsable des affaires institutionnelles mondiales, à compter du 16 avril 2026	CI
01/04	Adlai Nortye Ltd. annonce un changement de présidence, effectif au 1er avril 2026	CI
26/02	Daiichi Sankyo Company, Limited annonce des départs au sein de son conseil d'administration, effectifs au 31 mars 2026	CI
26/02	Daiichi Sankyo Company, Limited annonce le départ à la retraite de Sunao Manabe, Président Exécutif du Conseil d'Administration, effectif le 26 février 2026	CI
24/02	Daiichi Sankyo Company, Limited annonce des changements dans sa direction à compter du 1er avril 2026	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Daiichi Sankyo Company, Limited

Insider

Fonctions occupées

DepuisJusqu'au

Sunao Manabe

Director/Board Member	01/06/2014	-
Chief Executive Officer	01/06/2019	01/04/2025
Chairman	01/04/2023	31/03/2026
Chief Operating Officer	01/04/2017	01/06/2019
Human Resources Officer	01/06/2016	01/04/2017
Corporate Officer/Principal	01/04/2007	01/06/2016
President	01/04/2017	-
Sales & Marketing	01/04/2015	01/04/2016

Toshiaki Sai

Director/Board Member	01/06/2015	21/06/2021
Director of Finance/CFO	01/06/2018	21/06/2021
Investor Relations Contact	-	-
Public Communications Contact	01/04/2008	01/06/2014
Corporate Officer/Principal	01/04/2012	01/06/2018

Joji Nakayama

Director/Board Member	01/06/2010	01/04/2017
Chief Executive Officer	01/06/2010	01/06/2019
Chairman	01/04/2017	15/06/2020
President	01/06/2010	01/04/2017

Toshiaki Tojo

Director/Board Member	01/06/2016	15/06/2020
Corporate Officer/Principal	01/04/2010	15/06/2020

Kazunori Hirokawa

Chief Administrative Officer	01/04/2015	18/06/2018
Director/Board Member	01/06/2010	18/06/2018
Chief Tech/Sci/R&D Officer	01/04/2007	01/04/2012
Corporate Officer/Principal	01/04/2012	01/04/2015

Shuji Handa

Corporate Officer/Principal

01/04/2017

Takeshi Ogita

Director/Board Member	01/06/2009	20/06/2016
Chief Tech/Sci/R&D Officer	01/04/2010	01/04/2014
Human Resources Officer	01/04/2009	01/04/2014
Corporate Officer/Principal	01/04/2014	01/04/2016
Sales & Marketing	08/10/2010	01/04/2014

Yuki Sato

Director/Board Member	01/06/2011	20/06/2016
Human Resources Officer	01/04/2014	01/04/2016
General Counsel	01/04/2014	01/04/2015
Corporate Officer/Principal	01/04/2007	01/06/2014

Kazuo Koike

Comptroller/Controller/Auditor

04/07/2011

22/06/2015

Takashi Chiba

Comptroller/Controller/Auditor

04/07/2011

22/06/2015

Manabu Sakai

Chief Administrative Officer	01/06/2014	22/06/2015
Director/Board Member	01/06/2014	22/06/2015
Director of Finance/CFO	08/10/2010	24/01/2012
Corporate Officer/Principal	24/01/2012	01/06/2014

Kunio Ishihara

Director/Board Member

08/10/2010

22/06/2015

Hiroshi Hirabayashi

Director/Board Member

08/10/2010

22/06/2015

Noritaka Uji

Director/Board Member	01/06/2014	15/06/2020
Chairman	15/06/2020	-
Independent Dir/Board Member	01/06/2014	-

Takashi Okimoto

Director/Board Member

06/01/2010

01/06/2012

Toru Kuroda

Corporate Officer/Principal

01/01/2000

01/06/2011

Yuichiro Anzai

Director/Board Member

08/10/2010

Kiyoshi Morita

Chairman

06/01/2010

28/06/2010

Ryuzo Takada

Director/Board Member	06/01/2010	28/06/2010
Corporate Officer/Principal	06/01/2010	-
Sales & Marketing	06/01/2010	28/06/2010

Jotaro Yabe

Director/Board Member

06/01/2010

28/06/2010

Kunio Nihira

Director/Board Member

06/01/2010

28/06/2010

Yoshifumi Nishikawa

Director/Board Member

06/01/2010

28/06/2010

Francis Plat

Corporate Officer/Principal

01/01/2005

01/01/2009

Katsumi Fujimoto

Director/Board Member	01/06/2016	-
Corporate Officer/Principal	01/04/2007	01/04/2019

Hitoshi Matsuda

Director/Board Member

06/01/2010

Ryoichi Watanabe

Comptroller/Controller/Auditor	01/04/2007	-
Director of Finance/CFO	01/04/2009	01/04/2015
Investor Relations Contact	01/04/2007	01/04/2016

Akira Nagano

Public Communications Contact	24/01/2012	-
Corporate Officer/Principal	08/10/2010	24/01/2012

Hideyuki Haruyama

Comptroller/Controller/Auditor	01/06/2015	-
Corporate Officer/Principal	01/04/2007	01/06/2015

Hikaru Nagata

Comptroller/Controller/Auditor

08/10/2010

Teruo Takayanagi

Comptroller/Controller/Auditor

06/01/2010

Tsutomu Une

Director/Board Member	04/07/2011	-
Corporate Officer/Principal	04/07/2011	30/04/2012

Takashi Shoda

Chairman	08/10/2010	-
Corporate Officer/Principal	08/10/2010	08/10/2010
President	26/05/2009	08/10/2010

Keiji Sawamukai

Corporate Officer/Principal

01/01/2001

Glenn Gormley

Chief Tech/Sci/R&D Officer	-	31/03/2019
Corporate Officer/Principal	01/04/2019	-

Junichi Koga

Chief Tech/Sci/R&D Officer	-	01/04/2019
Corporate Officer/Principal	-	-

Ichiro Kanazawa

Director/Board Member

Seiji Sugiyama

Director/Board Member

Ryoji Nagasaka

Corporate Officer/Principal	-	01/04/2016
Corporate Secretary	01/04/2015	-

Dalton Einhorn

Corporate Officer/Principal

Shinichi Terano

Corporate Officer/Principal	04/07/2011	24/01/2012
Sales & Marketing	-	-

Satoshi Kunitada

Corporate Officer/Principal

08/10/2010

Katsuaki Miyoshi

Corporate Officer/Principal	04/07/2011	24/01/2012
Sales & Marketing	08/10/2010	-

Noriaki Ishida

Public Communications Contact	01/06/2014	-
Corporate Officer/Principal	08/10/2010	01/06/2014

Tomoo Yokoi

Comptroller/Controller/Auditor	08/10/2010	-
Director of Finance/CFO	08/10/2010	-
Corporate Officer/Principal	08/10/2010	08/10/2010

Haruhisa Kubota

Corporate Officer/Principal

08/10/2010

Ryoichi Kibushi

Sales & Marketing

08/10/2010

Jeff Halperin

Corporate Officer/Principal

Kazuhiko Tanzawa

Corporate Officer/Principal

08/10/2010

Yoshikazu Takano

Chief Administrative Officer	24/01/2012	-
Public Communications Contact	08/10/2010	24/01/2012

Audrey L. Hill

Corporate Officer/Principal

Kyohei Nonose

Human Resources Officer	08/10/2010	24/01/2012
Corporate Officer/Principal	24/01/2012	-

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	23
Femme	1

Dont comité exécutif

Homme	10
Femme	0

Dont Administrateurs

Homme	8
Femme	1

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Non

Conforme à la finance Islamique

Daiichi Sankyo Co., Ltd. est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Le CA par activité se répartit comme suit : - vente de médicaments (99,9%) : médicaments de prescription (95,3% du CA) et médicaments OTC (4,7%) destinés essentiellement au traitement des troubles thrombotiques, des tumeurs, du diabète et de la polyarthrite rhumatoïde ; - autres (0,1%) : notamment activités immobilières. La répartition géographique du CA est la suivante : Japon (37,4%), Amérique du Nord (31,2%), Europe (19,4%) et autres (12%).

Employés

20 171

Secteur

Produits pharmaceutiques

Agenda

Publication des résultats - Q1 2027

Plus d'informations sur la société